Guardant Health Inc (GH)
30.98
+0.30
(+0.98%)
USD |
NASDAQ |
Nov 21, 16:00
31.28
+0.30
(+0.97%)
Pre-Market: 08:09
Guardant Health Enterprise Value: 3.971B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 3.971B |
| November 20, 2024 | 3.933B |
| November 19, 2024 | 3.933B |
| November 18, 2024 | 3.721B |
| November 15, 2024 | 3.740B |
| November 14, 2024 | 3.875B |
| November 13, 2024 | 4.048B |
| November 12, 2024 | 3.816B |
| November 11, 2024 | 3.770B |
| November 08, 2024 | 3.678B |
| November 07, 2024 | 3.675B |
| November 06, 2024 | 3.268B |
| November 05, 2024 | 3.049B |
| November 04, 2024 | 3.059B |
| November 01, 2024 | 2.985B |
| October 31, 2024 | 2.838B |
| October 30, 2024 | 2.984B |
| October 29, 2024 | 2.826B |
| October 28, 2024 | 2.877B |
| October 25, 2024 | 2.669B |
| October 24, 2024 | 2.631B |
| October 23, 2024 | 2.658B |
| October 22, 2024 | 2.649B |
| October 21, 2024 | 2.709B |
| October 18, 2024 | 2.776B |
| Date | Value |
|---|---|
| October 17, 2024 | 2.690B |
| October 16, 2024 | 2.806B |
| October 15, 2024 | 2.798B |
| October 14, 2024 | 2.771B |
| October 11, 2024 | 2.778B |
| October 10, 2024 | 2.681B |
| October 09, 2024 | 2.716B |
| October 08, 2024 | 2.735B |
| October 07, 2024 | 2.772B |
| October 04, 2024 | 2.872B |
| October 03, 2024 | 2.828B |
| October 02, 2024 | 2.897B |
| October 01, 2024 | 2.867B |
| September 30, 2024 | 2.968B |
| September 27, 2024 | 2.921B |
| September 26, 2024 | 2.902B |
| September 25, 2024 | 2.849B |
| September 24, 2024 | 2.881B |
| September 23, 2024 | 2.996B |
| September 20, 2024 | 3.193B |
| September 19, 2024 | 3.230B |
| September 18, 2024 | 3.191B |
| September 17, 2024 | 3.193B |
| September 16, 2024 | 3.228B |
| September 13, 2024 | 3.402B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.970B
Minimum
Apr 19 2024
17.02B
Maximum
Feb 12 2021
6.567B
Average
5.680B
Median
Apr 02 2020
Enterprise Value Benchmarks
| Exact Sciences Corp | 11.37B |
| Delcath Systems Inc | 302.95M |
| Star Equity Holdings Inc | 33.41M |
| CytoSorbents Corp | 56.79M |
| Progyny Inc | 1.039B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -107.75M |
| Revenue (Quarterly) | 191.48M |
| Total Expenses (Quarterly) | 308.80M |
| EPS Diluted (Quarterly) | -0.88 |
| Gross Profit Margin (Quarterly) | 61.10% |
| Profit Margin (Quarterly) | -56.28% |
| Earnings Yield | -13.69% |
| Normalized Earnings Yield | -13.69 |